Sophie Brouard
Fondatore presso BioMAdvanced Diagnostics SAS
Profilo
Sophie Brouard was the founder of Effimune SA (founded in 2007) where she held the title of Director.
She is also the founder of BioMAdvanced Diagnostics SAS.
Currently, Dr. Brouard holds the position of Research Director at both Institut National de la Santé & de la Recherche Médicale and Centre National de la Recherche Scientifique.
Previously, she held the position of Director at Fondation Centaure and Director at Société Française D Immunologie.
She also served as an Independent Director at OSE Immunotherapeutics SA. Dr. Brouard received a graduate degree from Harvard Medical School.
Posizioni attive di Sophie Brouard
Società | Posizione | Inizio |
---|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Corporate Officer/Principal | - |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
BioMAdvanced Diagnostics SAS
BioMAdvanced Diagnostics SAS Medical SpecialtiesHealth Technology BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Sophie Brouard
Società | Posizione | Fine |
---|---|---|
Société Française D Immunologie | Direttore/Membro del Consiglio | - |
OSE IMMUNOTHERAPEUTICS | Direttore/Membro del Consiglio | - |
Fondation Centaure | Direttore/Membro del Consiglio | - |
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Fondatore | - |
Formazione di Sophie Brouard
Harvard Medical School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OSE IMMUNOTHERAPEUTICS | Health Technology |
Aziende private | 6 |
---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
Fondation Centaure | |
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |
Société Française D Immunologie | |
BioMAdvanced Diagnostics SAS
BioMAdvanced Diagnostics SAS Medical SpecialtiesHealth Technology BioMAdvanced Diagnostics SAS produces molecular diagnostic and biomarker tests related to the immune system. The company is based in Nantes, France. The French company was founded by Nicolas Bouler, Frédéric Pette, Sophie Brouard, Jean-Michel Bouler. Frédéric Pette has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Sophie Brouard